Ilias Mohammed

• Led the global out-license, in-license and other strategic alliances function • Co-led the global portfolio management • Co-led M&A projects in commercial due diligence, negotiations and deal closure phases • Co-led the corporate strategy of the company to achieve a growth of 20% until 2022 • Presented quarterly and yearly business development status quo & plans to upper management • Represented and built international network

• Led the complete chain of business development activities from prospection and evaluation to contract management for product or molecule or technologies acquisition or divestment including management of alliance • Responsible for in-depth analysis of third party offerings and feasibility of targeted business expansion possibilities to ensure profitable deals • Presented detailed strategic business development and strategic alliances plan annually to the upper management

• Supported business development with the search and evaluation of new business opportunities and assisted in due-diligence and deal closure • Supported in the development of corporate business plans for organic and inorganic growth • Led the innovation group towards identifying the new trends and market needs • Identified new business opportunities by performing market research & analysis from the available solutions, strategies and issues facing by pharmaceutical and healthcare industries

• Managed the relationships with partner organisations for potential business opportunities • Performed thorough market research and analysis for commercial opportunities • Defined requirements for performance improvement and planning process

Economics & General Management